Stephanie L Safgren

6PUBLICATIONS
71CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)NeonatologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

|Feb 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial.

Adam L Green, Charles G Minard, Xiaowei Liu

|Feb 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming.

Wazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini

|Dec 09, 2022
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia.

Qi Jin, Blanca Gutierrez Diaz, Tim Pieters

|Nov 19, 2021
De novo PBX1 variant in a patient with glaucoma, kidney anomalies, and developmental delay: An expansion of the CAKUTHED phenotype.

Stephanie L Safgren, Rory J Olson, Filippo Pinto E Vairo

|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.

Ryan M Carr, Denis Vorobyev, Terra Lasho

Pageof 1

Frequent Collaborators

2 joint publications

Elizabeth Fox

2 joint publications

Brenda J Weigel

2 joint publications

Joel M Reid

2 joint publications

Stephan Voss